This page uses content from Wikipedia and is licensed under CC BY-SA.

Allylescaline

Allylescaline
Allylescaline.svg
Allylescaline-3d-sticks.png
Names
Preferred IUPAC name
2-{3,5-Dimethoxy-4-[(prop-2-en-1-yl)oxy]phenyl}ethan-1-amine
Other names
2-[4-(Allyloxy)-3,5-dimethoxyphenyl]ethan-1-amine
2-[4-(Allyloxy)-3,5-dimethoxyphenyl]ethanamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
Properties
C13H19NO3
Molar mass 237.299 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

Allylescaline (4-allyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is closely related in structure to mescaline. Allylescaline was first synthesized by Otakar Leminger in 1972.[1] The compound was later synthesized by Alexander Shulgin and further described in his book PiHKAL.[2] The dosage range is listed as 20–35 mg, and the duration 8-12 hours.[2] Allylescaline produces an entactogenic warmth, an entheogenic effect, and a feeling of flowing energy. Very little data exists about the pharmacological properties, metabolism, and toxicity of allylescaline.

Legal status

Allylescaline is illegal in Sweden as of January 2016.[3]

See also

References

  1. ^ Leminger, Otakar (1972). "The Chemistry of Alkoxylated Phenethylamines - Part 2". Chemický průmysl. 22: 553.
  2. ^ a b AL Entry in PiHKAL
  3. ^ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.